The intracerebral application of the PPARγ‐ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain

Y Zhao, A Patzer, P Gohlke… - European Journal of …, 2005 - Wiley Online Library
Y Zhao, A Patzer, P Gohlke, T Herdegen, J Culman
European Journal of Neuroscience, 2005Wiley Online Library
The present study addresses the neuroprotective function of intracerebroventricular (icv)
application of pioglitazone, a selective ligand of the peroxisome proliferator‐activated
receptor gamma (PPARγ) in the rat brain after ischaemia. Pioglitazone or vehicle were icv
infused via osmotic minipumps over a 5‐day period before, and 2 days after transient middle
cerebral artery occlusion (MCAO) for 90 min. This icv application of pioglitazone in the brain
significantly reduced the infarct size and brain oedema, and attenuated in the peri‐infarct …
Abstract
The present study addresses the neuroprotective function of intracerebroventricular (i.c.v.) application of pioglitazone, a selective ligand of the peroxisome proliferator‐activated receptor gamma (PPARγ) in the rat brain after ischaemia. Pioglitazone or vehicle were i.c.v. infused via osmotic minipumps over a 5‐day period before, and 2 days after transient middle cerebral artery occlusion (MCAO) for 90 min. This i.c.v. application of pioglitazone in the brain significantly reduced the infarct size and brain oedema, and attenuated in the peri‐infarct cortical regions the invasion of activated microglia and macrophages. Moreover, pioglitazone improved the recovery of sensory deficits 48 h after MCAO. Our data demonstrate for the first time that it is the activation of intracerebral PPARγ that can confer neuroprotection, anti‐inflammatory and neurological improvement following ischaemic injury.
Wiley Online Library